Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2013-003056-21-DE
EUCTR2013-003056-21-DE
Active, not recruiting
Phase 1

Evaluation of an additional therapeutic approach to diabetic macular edema by combining standard therapy (intravitreal injection of a VEGF-inhibitor) with micropulse diode laser treatment in a randomized, controlled proof of concept study - ReCa

GWT-TUD GmbH0 sitesDecember 18, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsvisual impairment due to diabetic macular edemaMedDRA version: 18.0Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]
DrugsLucentis

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
visual impairment due to diabetic macular edema
Sponsor
GWT-TUD GmbH
Status
Active, not recruiting
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 18, 2013
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients at least 18 years with DME and 0\.05 \< BCVA \< 0\.6 or retinal thickness \>300 µm (determined by SD\-OCT)
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 30
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 20

Exclusion Criteria

  • •\- Severe ischemic maculopathy of the study eye
  • •\- Active neovascularization of iris or retina in the study eye
  • •\- History of intravitreal injection of VEGF\-inhibitor or steroids in study eye within the last 3 month
  • •\- Pathologies of the anterior segment of the study eye with reduced visual acuity (e.g. corneal opacification, advanced cataract)
  • •\- Advanced glaucoma with central defects of the visual field in study eye
  • •\- Retinal pathologies with reduced visual (e.g. central scars, age related macular degeneration) in study eye
  • •\- Retinal vascular occlusion in medical history of study eye
  • •\- Active or suspected ocular or periocular infections
  • •\- Active intraocular inflammation in study eye
  • •\- Intraocular surgery of study eye within the last 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Evaluation of therapeutic effect, technique optimization and individual program of three different wrench methods for atlantoaxial joint dislocatioChronic Nonspecific Neck Pain
ITMCTR2024000187The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Recruiting
Not Applicable
Clinical study for the therapeutic evaluation and mechanism of auricular points therapy for examination syndrome
ITMCTR1900002565Guangdong Provincial Hospital of Chinese Medicine
Completed
Not Applicable
Testing the effectiveness of an add-on treatment for impingement syndrome stage I and II - Marnitz therapy as a combination partner for standardized physiotherapy - Pilot StudyM75.4Impingement syndrome of shoulder
DRKS00005338Institut für Gesundheits- und PflegewissenschaftMedizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg18
Active, not recruiting
Not Applicable
Evaluation the effectiveness and additional treatment period of different wear times in at-home dental bleaching
RBR-62yhd5kFaculdade de Odontologia de Araçatuba
Recruiting
Not Applicable
An intervention study to improve therapeutic compliance in adult patients with eosinophilic esophagitis.allergic esophagitisEosinophilic esophagitis10017969
NL-OMON51510Amsterdam UMC72